Wed Jan 27th, 2021 at 09:26:23 PM EST
AstraZeneca cannot play the Britain First card of nationalism ... the EU invested in production facilities in 4 locations ... included two UK factories.
More below the fold ...
EU health official blasts slow vaccine delivery, and is consulting with Canada
Vaccine maker AstraZeneca was the recipient of the scathing message from Stella Kyriakides, European commissioner for health and food safety, dring a briefing in Brussels.
Kyriakides said buying vaccines during a pandemic shouldn't be treated like a first-come, first-served trip to a neighbourhood butcher shop when people are dying in large numbers.
EU demands UK Covid vaccines from AstraZeneca to make up shortfall | FT |
The EU has said AstraZeneca must take coronavirus vaccines from UK factories to make up a shortfall in supplies to its member states, a demand that could unleash an explosive post-Brexit political fight.
AstraZeneca was contractually obliged to use vaccines produced at UK plants to fulfil its delivery obligations to EU states, the European Commission said, as Brussels called on the manufacturer to agree to publish its EU supply contract.
Early agreement between Oxford/AstraZeneca and four EU countries ...
Four European nations to pay $843 million for AstraZeneca's coronavirus vaccine
The news comes two days after AstraZeneca announced on Saturday it had agreed with the four countries to supply up to 400 million doses of the vaccine, with deliveries set to start by the end of 2020. The pharmaceutical giant said it was building a number of supply chains in parallel across the world and is seeking to expand manufacturing capacity further.
AstraZeneca has recently completed similar agreements with the U.K. and U.S. and the Coalition for Epidemic Preparedness Innovations and vaccine alliance Gavi for 700 million doses. It added on Saturday that it had agreed a license with the Serum Institute of India for the supply of an additional 1 billion doses, principally for low and middle-income countries. Total manufacturing capacity currently stands at 2 billion doses, the company said.